MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹179 Cr | ₹141 Cr | ₹115 Cr | ₹11,271,608 Cr | ₹126 Cr |
What is the latest Revenue of MEDICAMEN BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹179 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹11,271,608 Cr |
| Mar2021 | ₹126 Cr |
How is Revenue of MEDICAMEN BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹179 Cr | 27.29 | |
| Mar2024 | ₹141 Cr | 22.02 | |
| Mar2023 | ₹115 Cr | -100.00 | |
| Mar2022 | ₹11,271,608 Cr | 8,980,974.92 | |
| Mar2021 | ₹126 Cr | - | |
Compare Revenue of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹376.8 Cr | -5.4% | 14.3% | -35.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -5.4% |
14.3% |
-35.5% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses